MARKETWIRE.NET

Decode Your Next Market Move

Find Out More About Regions, Brands, Dominant, Active & Niche Companies Covered in the Report

22 October 2:11 A.M., Silicon Valley, California-

Amid the COVID-19 crisis, the global market for Veterinary Molecular Diagnostics estimated at US$468.5 Million in the year 2020, is projected to reach a revised size of US$769 Million by 2027, growing at a CAGR of 7.3% over the analysis period 2020-2027. Instruments & Software, one of the segments analyzed in the report, is projected to record a 7.2% CAGR and reach US$269.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Kits & Reagents segment is readjusted to a revised 8.1% CAGR for the next 7-year period.

The Veterinary Molecular Diagnostics market in the U.S. is estimated at US$126.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$170 Million by the year 2027 trailing a CAGR of 11.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4% and 6.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.
In the global Services segment, USA, Canada, Japan, China and Europe will drive the 5.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$87 Million in the year 2020 will reach a projected size of US$128 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$105.8 Million by the year 2027, while Latin America will expand at a 7.4% CAGR through the analysis period. We bring years of research experience to this 8th edition of our report. The 372-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Key Competitors Covered in the Report -
Thermo Fisher Scientific, Inc.
QIAGEN NV
Bioneer Corporation
Novacyt Group
Vca, Inc.
BIOMEDICA Medizinprodukte GmbH
HealthGene Corporation

Segments Covered in the Report -
End-Use (Hospitals/Clinics, Reference Laboratories)
Product Segment (Instruments & Software, Kits & Reagents, Services)
Technology Type (Polymerase Chain Reaction (PCR), Microarrays, DNA Sequencing)

Geographies Analyzed in the Report -
World
United States
Canada
Japan
China
Europe (France
Germany
Italy
United Kingdom
Spain
Russia
and Rest of Europe)
Asia-Pacific (Australia
India
South Korea
and Rest of Asia-Pacific)
Latin America (Argentina
Brazil
Mexico
and Rest of Latin America)
Middle East (Iran
Israel
Saudi Arabia
United Arab Emirates
and Rest of Middle East)
and Africa.

View Executive Engagement Dashboards, COVID Impact Questionnaires & Get Complimentary Access to Methodology & Full-Text Secondary Sources

For enquiries e-mail us at sales@strategyR.com .

For cutting edge analyst reviews on top industries, follow us on Twitter and connect with us on LinkedIn

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) (www.strategyr.com) is the world`s only influencer driven AI powered market research company. Serving more than 41,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for 33 years, offering the widest coverage of topics, geographic markets, competitive brands, and companies profiled.

Contact Us:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
Email: sales@StrategyR.com